Without the help of genomics specialists, it is hard for health plans to manage genomic benefits efficiently and effectively. Now is the time for health plans to evaluate their genomic benefits management programs to find the right expert guidance and utilization management support.
Many genetic findings are ambiguous, leaving doctors uncertain about whether a particular variant is truly dangerous.
Discover Houston's best orthopedic surgery centers and what features — from personalized treatment plans to rehabilitation services — make these top providers stand out in their industry.
Unlike inherited genetic predispositions, accumulated genetic changes are the result of environmental influences, such as smoking, chemicals or ultra-violet radiation. A growing body of research links somatic changes to an increased likelihood of blood cancers and cardiovascular disease, both heart disease and stroke.
Molecular diagnostics companies have laid the foundation for nothing short of a revolution in cancer care — it’s time for the medtech sector to develop tools to make genomic testing accessible to the masses.
With more individuals exploring their family tree, it’s reasonable to believe many of them are als intent to get a handle on their potential for various hereditary diseases. With that in mind, Ochsner Health has launched a digital population health pilot program.
To help cut down cancer disparities and deaths, OSF HealthCare recently announced that it will be expanding its genetic cancer risk assessment software into its Epic electronic health record for primary care practices.
Discover what tools are essential for efficient, safe surgical extractions in today’s health care landscape, from elevators to forceps and beyond.
The risks associated with ignoring genetic factors far exceed the complications of including them and going forward there will be more clinical trials having a genetic or precision medicine component to develop targeted therapies.
A recent study notes that widespread access to personal genetic information – without the knowledge of how to interpret results – can lead to problems ranging from misinterpretation to emotional distress.
The Food and Drug Administration has granted 23andMe the first-ever authorization for direct-to-consumer genetic testing for cancer risk without a prescription.
Distrust in genetic sequencing and medical testing abound, but the fact is that genomic medicine is a breakthrough tool for diagnosis and treatment.
The layout of your phlebotomy station can significantly impact efficiency. A well-thought-out setup ensures that every tool is within reach, minimizing unnecessary movement and reducing patient wait times.
A family member's liquid biopsy test, gene testing and a journey into coverage decisions and clinical guidelines reveal how difficult the reimbursement path is for these emerging technologies.